Gene · 4507
Papers2,281
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,281
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromophobe renal cell carcinoma with nodal involvement: A rare case report highlighting unusual molecular features. | Urol Case Rep | 2026 | 42433736 | PubTator, text mining | PubMed |
| MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylation. | Oncogene | 2026 | 42432327 | PubTator, text mining | PubMed |
| Using large-scale tissue microarray resources for the identification and evaluation of old, new, and novel targets for surgical pathology. | Pol J Pathol | 2026 | 42429420 | PubTator, text mining | PubMed |
| Synthetic lethality targets in pancreatic ductal adenocarcinoma: prevalence and limitations of liquid biopsy detection in a minority-serving cancer center. | Future Oncol | 2026 | 42422981 | PubTator, text mining | PubMed |
| Prolonged Survival in Metastatic Pancreatic Acinar Cell Carcinoma Treated with Hepatic Arterial Infusion of Oxaliplatin: A Case Report with Longitudinal Molecular Profiling. | Case Rep Oncol | 2026 | 42421759 | PubTator, text mining | PubMed |
| Tumor-type specific methylation patterns of MTAP in human samples and cell lines. | Clin Epigenetics | 2026 | 42421155 | PubTator, text mining | PubMed |
| Genomic Landscape and Clinical Impact of MTAP Loss in Driver-Positive NSCLC: Insights From a Large-Scale Real-World Chinese Cohort. | J Thorac Oncol | 2026 | 42409117 | PubTator, text mining | PubMed |
| Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer. | Clin Cancer Res | 2026 | 42405849 | PubTator, text mining | PubMed |
| Role of methionine metabolism in cancer: recent advances in molecular mechanisms and therapeutic implications. | Exp Hematol Oncol | 2026 | 42402595 | PubTator, text mining | PubMed |
| Harnessing tumor-agnostic biomarkers for precision medicine in lymphoma. | Cancer Treat Res Commun | 2026 | 42401005 | PubTator, text mining | PubMed |
| HER2-mutated lung squamous cell carcinoma responding to trastuzumab deruxtecan followed by pyrotinib: a Case Report. | Front Pharmacol | 2026 | 42394988 | PubTator, text mining | PubMed |
| A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies. | Cancer Res | 2026 | 42391326 | PubTator, text mining | PubMed |
| Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types. | Mol Med | 2026 | 42374173 | PubTator, text mining | PubMed |
| Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract Cancer. | Clin Cancer Res | 2026 | 42360806 | PubTator, text mining | PubMed |
| The Evolving Landscape of Immune Regulation and Immunotherapy in Cholangiocarcinoma and Biliary Tract Cancer. | Cancers (Basel) | 2026 | 42352533 | PubTator, text mining | PubMed |
| PRMT5 inhibitors in MTAP loss NSCLC with actionable genomic alterations: a new kid on the block? | Ann Oncol | 2026 | 42342327 | PubTator, text mining | PubMed |
| Genomic landscape and tumor immune microenvironment of osteosarcoma: Bridging mechanistic insights to precision therapeutics. | Bone Rep | 2026 | 42326738 | PubTator, text mining | PubMed |
Quantitative Global Proteomics of Formalin-Fixed Paraffin-Embedded Tumors Identifies Dimethylated G3BP1 at Arginine 460 as a Robust Pharmacodynamic Biomarker of Methylthioadenosine Phosphorylase-Selective Protein Arginine Methyltransferase 5 Inhibition. | J Proteome Res | 2026 | 42321016 | PubTator, text mining | PubMed |
| CTSC-RAB38 Potentiates Responsiveness to PD-1 Blockade in Esophageal Squamous Cell Carcinoma. | Genomics Proteomics Bioinformatics | 2026 | 42316836 | PubTator, text mining | PubMed |
| Structure-Guided Discovery of Novel Highly Potent and Selective MTA-Cooperative PRMT5 Inhibitors. | ACS Med Chem Lett | 2026 | 42305212 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4507/papers?page=3